Filter Results:
(2,236)
Show Results For
- All HBS Web
(4,847)
- People (16)
- News (1,868)
- Research (2,236)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,827)
Show Results For
- All HBS Web
(4,847)
- People (16)
- News (1,868)
- Research (2,236)
- Events (2)
- Multimedia (220)
- Faculty Publications (1,827)
Sort by
- 05 Jul 2006
- First Look
First Look: July 5, 2006
MaterialsAncora: A Private University in the Health Care of the Poor 306-088 Project Ancora signals the entry of the private sector into primary healthcare for Chile's poor. On a commercial basis, it seeks... View Details
Keywords: Sean Silverthorne
- 2007
- Book
Perspectives on Risk and Regulation: The FDA at 100
By: Arthur A. Daemmrich and Joanna Radin
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific... View Details
Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation
Daemmrich, Arthur A., and Joanna Radin, eds. Perspectives on Risk and Regulation: The FDA at 100. Chemical Heritage Foundation, 2007. (Fulltext.)
- 09 Oct 2012
- First Look
First Look: October 9
this time. Read the article: http://hbr.org/2012/10/great-leaders-dont-need-experience/ar/1 Working PapersTeam Scaffolds: How Minimal In-Group Structures Support Fast-Paced Teaming Authors:Melissa Valentine and Amy C. Edmondson Abstract Across many industries,... View Details
Keywords: Sean Silverthorne
- 19 Oct 2010
- First Look
First Look: October 19, 2010
a dominant reimbursement model, and for which patient health outcomes were universally measured and reported. In 1986, UCLA Medical Center was approached by Kaiser to develop a new bundled-pricing approach to kidney transplant View Details
Keywords: Sean Silverthorne
- October 2003 (Revised January 2005)
- Case
Shared Decision Making
By: Richard M.J. Bohmer, Karen Sepucha and Laura Feldman
The Foundation for Informed Medical Decision-Making has created an interactive videodisc system that provides patients with customized support regarding medical treatment or screening decisions when they face a choice between two equally effective courses of action.... View Details
Keywords: Decision Choices and Conditions; Borrowing and Debt; Health Care and Treatment; Innovation Strategy; Technological Innovation; Product Marketing; Distribution Channels; Production; Partners and Partnerships; Research and Development; Information Technology
Bohmer, Richard M.J., Karen Sepucha, and Laura Feldman. "Shared Decision Making." Harvard Business School Case 604-001, October 2003. (Revised January 2005.)
- 18 Feb 2015
- First Look
First Look: February 18
https://cb.hbsp.harvard.edu/cbmp/product/715411-PDF-ENG Harvard Business School Case 715-423 Discovery Limited Discovery Limited is a South-African based insurance company. Started in the early 1990s, Discovery used behavioral economics and data collection to innovate... View Details
Keywords: Sean Silverthorne
- 05 Aug 2015
- What Do You Think?
What Happened to the ‘Innovation, Disruption, Technology’ Dividend?
W. Norton & Company, 2014). Martin Ford, Rise of the Robots: Technology and the Threat of a Jobless Future (New York: Basic Books, 2015). James L. Heskett, W. Earl Sasser, Jr., and Leonard A. Schlesinger, What Great Service Leaders Know and Do: Creating... View Details
- 19 Dec 2014
- Research & Ideas
China’s Complicated Relationship With Mother Nature
Despite its name, the Great Wall of China began as a series of smaller, isolated defensive fortifications. Those structures grew and were later unified into the imposing structure that exists today. The Great Wall is a great metaphor for the Chinese economy. By... View Details
- 14 Apr 2015
- First Look
First Look: April 14
factors such as "firm culture" and "employee engagement" in driving firm performance? Increasing evidence from a wide range of fields suggests that productivity differs widely across firms, even after the inclusion of View Details
Keywords: Sean Silverthorne
- 15 Dec 2009
- First Look
First Look: Dec. 15, 2009
Publication:Academic Medicine 84, no. 12 (December 2009): 1663-1671 Abstract Recent focus on the need to improve the quality and safety of health care has created new challenges for academic View Details
Keywords: Martha Lagace
- 19 Dec 2017
- First Look
New Research and Ideas, December 19, 2017
is likely to have a meaningful effect on health care spending patterns. In addition, precision medicines can change the expected profitability of therapies both by allowing more sophisticated pricing systems... View Details
Keywords: Carmen Nobel
- 12 Apr 2011
- First Look
First Look: April 12
Universal Health Care Is the Best Solution Authors: Regina E. Herzlinger Publication: In Current Controversies: Health Care, edited by Noel Merino. Farmington Hills, MI:... View Details
Keywords: Sean Silverthorne
- May 2018
- Case
The Multiple Myeloma Research Foundation's Answer Fund
By: Richard G. Hamermesh and Matthew G. Preble
Keywords: Data Analytics; Customer Focus and Relationships; Customer Relationship Management; Cost vs Benefits; Investment Return; Health Care and Treatment; Innovation Leadership; Intellectual Property; Knowledge Sharing; Knowledge Dissemination; Leadership; Leading Change; Resource Allocation; Goals and Objectives; Marketing Communications; Performance; Programs; Projects; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Research and Development; Genetics; Behavior; Motivation and Incentives; Social and Collaborative Networks; Nonprofit Organizations; Strategy; Health Industry; Health Industry; Health Industry; United States
- 02 Aug 2016
- First Look
August 2, 2016
Healthcare Partners Inc. (DaVita), in August 2013. The two would discuss whether Golomb should lead a new DaVita venture, Paladina Health (Paladina), which operated a network of primary care clinics. DaVita... View Details
Keywords: Sean Silverthorne
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- 18 Apr 2017
- First Look
First Look at New Ideas, April 18
Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/817064-PDF-ENG Harvard Business School Case 217-021 Bayer AG: Bidding to Win Merck's OTC Business Shortly after submitting their best and final offer to acquire Merck's Consumer View Details
Keywords: by Sean Silverthorne
- 06 Oct 2015
- First Look
October 6, 2015
at the Narayana Health City Cardiac Hospital (NH) in India. The case discusses the factors driving the adoption of task shifting at NH and identifies the implications of task shifting for surgeon training, surgical capacity, and procedure... View Details
Keywords: Sean Silverthorne
- 06 Aug 2013
- First Look
First Look: August 6
available. Purchase this case: http://hbr.org/search/313109-PDF-ENG Harvard Business School Case 112-085 Schön Klinik: Measuring Cost and Value The case illustrates how a leading German hospital group has invested deeply in the measurement of patient-level outcomes and... View Details
Keywords: Anna Secino
- 10 Jun 2002
- Research & Ideas
Disruption: The Art of Framing
potential shared resources. Johnson & Johnson has done this effectively with many of its health care companies—acquiring separate platforms of growth and leaving them largely independent. Knight Ridder... View Details
Keywords: by Clark Gilbert & Joseph L. Bower
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
R&D-intensive firms react to negative shocks to their existing products? We explore this question using detailed project-level data from drug development firms. Using FDA Public Health Advisories as an exogenous and idiosyncratic... View Details
Keywords: Dina Gerdeman